Preliminary results of a phase I/II study of paclitaxel, cisplatin, and cyclophosphamide in advanced ovarian carcinoma

Seminars in Oncology

Volumn 24, Issue 1 SUPPL. 2, 1997, Pages

  Coeffic, D ^a   Benhammouda, A ^a   Antoine, E C ^a   Rixe, O ^a   Paraiso, D ^a   Auclerc, G ^a   Renody, N ^a   Mularoni, E ^a   Soubrane, C ^a   Weil, M ^a   Mortier, N ^a   Khayat, D ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CISPLATIN; CYCLOPHOSPHAMIDE; DEXCHLORPHENIRAMINE; PACLITAXEL; PREDNISOLONE;

ADULT; AGED; ASTHENIA; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPENIA; ORAL DRUG ADMINISTRATION; OVARY CARCINOMA; PERIPHERAL NEUROPATHY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CYCLOPHOSPHAMIDE; FEASIBILITY STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PACLITAXEL; REMISSION INDUCTION;

EID: 0031055487     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)